Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 41kWORD 9k
15 October 2020
P-005642/2020
Priority question for written answer P-005642/2020
to the Commission
Rule 138
Martin Häusling (Verts/ALE)
 Subject: New genetic engineering technology: tests and testing procedures

National authorities are obliged to monitor compliance with the ‘Deliberate Release Directive’ (Directive 2001/18/EC). The CJEU judgment of 25 July 2018 sets out that plants produced with new genetic engineering technology must also be rated as genetically-modified organisms (GMOs) under the Directive. A soya plant produced with the new technology by the Calyxt company, for example, is being cultivated in the US.

1. Are national authorities able to test for products produced with new genetic engineering technology such as this kind of soya, which are not permitted in the EU?

2. What are the requirements governing the testing procedure for such products?

3. Do the same requirements apply to GMOs permitted in the EU as to GMOs not permitted in the EU?

Original language of question: DE
Last updated: 16 October 2020Legal notice - Privacy policy